Tender detail

Conclusion of a non-exclusive discount agreement for Elafibranor for 2026–2028

Summary

DAK-Gesundheit intends to conclude medicine discount agreements with interested pharmaceutical companies for medicines containing Elafibranor (ATC A05AX06). The agreements will run from 1 December 2026 to 30 November 2028, but will end earlier if an exclusive agreement enters into force.

Reference number
972fea22-3ff8-4934-9e17-caa5d6664d31
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-10-05
Status
Open
Contract subject
Supplies
Estimated value
1,00 EUR
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.